Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review

Abstract Background Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis (AE), is often found associated with tumors such as thymoma, lung cancer, ovarian tumors, and breast cancer, and the tumors were generally detect...

Full description

Bibliographic Details
Main Authors: Yue Huang, Muke Zhou, Jing Zhou, Bo Wu, Xi Yang, Wenjiao Min, Zhengyu Li
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Women's Health
Subjects:
Online Access:https://doi.org/10.1186/s12905-023-02636-1
_version_ 1797556783763423232
author Yue Huang
Muke Zhou
Jing Zhou
Bo Wu
Xi Yang
Wenjiao Min
Zhengyu Li
author_facet Yue Huang
Muke Zhou
Jing Zhou
Bo Wu
Xi Yang
Wenjiao Min
Zhengyu Li
author_sort Yue Huang
collection DOAJ
description Abstract Background Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis (AE), is often found associated with tumors such as thymoma, lung cancer, ovarian tumors, and breast cancer, and the tumors were generally detected during the screening process after the encephalitis initiated. The tumor is considered a trigger of AE, but the mechanism remains unclear. Case Presentation A 53-year-old woman presented short-term memory loss two days after the primary cytoreduction for high-grade serous ovarian cancer (HGSOC, FIGO stage IC3). Cell-based assay found AMPAR CluA2 IgG positive in both serum (1:3.2) and cerebrospinal fluid (1:32). Moreover, mild AMPAR GluA1 and strong GluA2 expressions were also found positive in the paraffin sections of ovarian tumor tissue, indicating the ovarian cytoreduction surgery might stimulate the release of receptor antigens into the circulation system. The patient’s condition deteriorated within two weeks, developing consciousness and autonomic dysfunction, leading to ICU admission. With oral steroids, intravenous immunoglobulin, plasmapheresis, and rituximab treatment, the patient’s consciousness markedly improved after three months. Conclusion We presented the first case of anti-AMPAR encephalitis developed right after the primary cytoreduction of a patient with HGSOC and retrieved paraneoplastic anti-AMPAR encephalitis cases (n = 66). Gynecologists should pay attention to patients who develop cognitive dysfunction or psychiatric symptoms shortly after the ovarian tumor resection and always include AE in the differentiation diagnosis.
first_indexed 2024-03-10T17:06:52Z
format Article
id doaj.art-6570b6bd563f4d1388d0bb226a7e9f7e
institution Directory Open Access Journal
issn 1472-6874
language English
last_indexed 2024-03-10T17:06:52Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Women's Health
spelling doaj.art-6570b6bd563f4d1388d0bb226a7e9f7e2023-11-20T10:46:21ZengBMCBMC Women's Health1472-68742023-09-012311810.1186/s12905-023-02636-1Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature reviewYue Huang0Muke Zhou1Jing Zhou2Bo Wu3Xi Yang4Wenjiao Min5Zhengyu Li6Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan UniversityDepartment of Neurology, West China Hospital, Sichuan UniversityDepartment of Gynecology and Obstetrics, Chengdu Fifth People’s HospitalDepartment of Neurology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, West China Hospital, Sichuan universityDepartment of Psychosomatic Medicine, Sichuan Academy of Medical Science & Sichuan Provincial People’s HospitalDepartment of Gynecology and Obstetrics, West China Second University Hospital, Sichuan UniversityAbstract Background Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis (AE), is often found associated with tumors such as thymoma, lung cancer, ovarian tumors, and breast cancer, and the tumors were generally detected during the screening process after the encephalitis initiated. The tumor is considered a trigger of AE, but the mechanism remains unclear. Case Presentation A 53-year-old woman presented short-term memory loss two days after the primary cytoreduction for high-grade serous ovarian cancer (HGSOC, FIGO stage IC3). Cell-based assay found AMPAR CluA2 IgG positive in both serum (1:3.2) and cerebrospinal fluid (1:32). Moreover, mild AMPAR GluA1 and strong GluA2 expressions were also found positive in the paraffin sections of ovarian tumor tissue, indicating the ovarian cytoreduction surgery might stimulate the release of receptor antigens into the circulation system. The patient’s condition deteriorated within two weeks, developing consciousness and autonomic dysfunction, leading to ICU admission. With oral steroids, intravenous immunoglobulin, plasmapheresis, and rituximab treatment, the patient’s consciousness markedly improved after three months. Conclusion We presented the first case of anti-AMPAR encephalitis developed right after the primary cytoreduction of a patient with HGSOC and retrieved paraneoplastic anti-AMPAR encephalitis cases (n = 66). Gynecologists should pay attention to patients who develop cognitive dysfunction or psychiatric symptoms shortly after the ovarian tumor resection and always include AE in the differentiation diagnosis.https://doi.org/10.1186/s12905-023-02636-1Anti-AMPAR encephalitisParaneoplastic syndromeOvarian cancerCytoreduction surgeryCase report
spellingShingle Yue Huang
Muke Zhou
Jing Zhou
Bo Wu
Xi Yang
Wenjiao Min
Zhengyu Li
Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
BMC Women's Health
Anti-AMPAR encephalitis
Paraneoplastic syndrome
Ovarian cancer
Cytoreduction surgery
Case report
title Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
title_full Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
title_fullStr Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
title_full_unstemmed Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
title_short Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review
title_sort anti alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery a case report and literature review
topic Anti-AMPAR encephalitis
Paraneoplastic syndrome
Ovarian cancer
Cytoreduction surgery
Case report
url https://doi.org/10.1186/s12905-023-02636-1
work_keys_str_mv AT yuehuang antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT mukezhou antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT jingzhou antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT bowu antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT xiyang antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT wenjiaomin antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview
AT zhengyuli antialphaamino3hydroxy5methyl4isoxazolepropionicacidreceptorencephalitisdevelopedafterovariancancercytoreductionsurgeryacasereportandliteraturereview